How is the Tetanus Severity Score calculated and interpreted for assessing mortality risk in tetanus patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tetanus Severity Score

The Tetanus Severity Score (TSS) is a validated prognostic tool that uses clinical parameters to predict mortality risk in tetanus patients, demonstrating superior discriminatory ability compared to older scoring systems like the Phillips and Dakar scores. 1

How the TSS is Calculated

The TSS was developed through multivariate logistic regression analysis using prospectively collected data from 1,822 consecutive tetanus patients. The score incorporates multiple clinical variables assessed at admission to stratify patients by mortality risk. 1

Performance Characteristics

The TSS demonstrates robust predictive accuracy:

  • Sensitivity: 77% (resubstitution testing) and 65% (prospective validation)
  • Specificity: 82% (resubstitution testing) and 91% (prospective validation)
  • Area under ROC curve: 0.89 (95% CI 0.88-0.90), significantly outperforming both the Phillips score (0.66) and Dakar score (0.74) 1

Clinical Interpretation and Mortality Risk

Shorter incubation periods (time from injury to symptom onset) are strongly associated with more severe disease and higher mortality risk. 2 The median incubation period is 7 days, with a range of 3-21 days, though extremes of 1 day to several months can occur.

Key Prognostic Factors

Age ≥60 years is a critical mortality predictor, with significantly elevated odds of death (OR 6.25,95% CI 1.02-38.08). 3 The case-fatality ratio is highest in infants and elderly patients, reaching 10-20% even in modern healthcare facilities. 2

Ablett Grade IV disease (the most severe classification) carries a 44.4% mortality rate. 3 Patients with severe tetanus typically require:

  • ICU admission (96.55% of severe cases)
  • Mechanical ventilation (89.66% of severe cases)
  • Prolonged hospitalization (mean 28.4 days vs. 15 days for non-severe cases)
  • Substantially higher costs 4

Overall Mortality Data

Current U.S. surveillance data (2001-2016) shows an overall case-fatality rate of 8.0%, down from 18% in 1998-2000. 2 However, the overall case-fatality rate among persons with known vital status is 12.4%, with deaths predominantly affecting older adults. 5

Clinical Application

The TSS should be used at admission to guide clinical triage, determine ICU need, and inform family discussions about prognosis. 1 The score's superior discrimination makes it the preferred tool over older classification systems for:

  • Identifying high-risk patients requiring intensive monitoring
  • Allocating critical care resources appropriately
  • Standardizing research enrollment criteria
  • Providing objective prognostic information

Common Pitfalls

Do not rely solely on the Phillips score, which has poor specificity (20%) and tends to over-predict mortality. 1 Similarly, the Dakar score has inadequate sensitivity (13%) and will miss the majority of patients who will die. 1

Recognize that incubation period inversely correlates with severity - patients presenting within days of injury have worse prognosis than those with longer incubation periods, as shorter intervals indicate wounds closer to the central nervous system. 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.